Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in

Clinical Trial Summary

This study is a post-marketing surveillance of lenvatinib in participants with unresectable thyroid cancer. The objectives of this study are to capture unknown adverse reactions, incidences of adverse drug reaction, efficacy, factors considered to have effect to safety and effectiveness, and incidences of hypertension, hemorrhagic events and thromboembolic event, and liver disorder.

See also
Status	Clinical Trial	Phase
Completed	`NCT00537095` - Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer	Phase 2
Recruiting	`NCT04139096` - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed	`NCT00754182` - Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision	N/A
Completed	`NCT00094055` - Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer	Phase 2
Completed	`NCT00148213` - Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma	N/A
Recruiting	`NCT06398795` - Dual-port Trans-subclavian Thyroid Endoscopic Surgery	N/A
Recruiting	`NCT01005654` - Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Active, not recruiting	`NCT05579782` - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy	N/A
Completed	`NCT01437254` - To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer	Phase 1
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed	`NCT00984282` - Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer	Phase 3
Completed	`NCT01292044` - The Role of Elastography in the Diagnosis of Thyroid Nodules	N/A
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Active, not recruiting	`NCT02418247` - Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer	Phase 2/Phase 3
Completed	`NCT00467506` - Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma	Phase 2
Recruiting	`NCT04396912` - Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
Enrolling by invitation	`NCT04411290` - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Recruiting	`NCT04410601` - Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT	N/A
Completed	`NCT03469310` - Minimizing Narcotic Analgesics After Endocrine Surgery	Phase 4
Completed	`NCT03871387` - The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change	N/A

NCT number	NCT02430714
Study type	Observational
Source	Eisai Inc.
Contact
Status	Completed
Phase
Start date	May 20, 2015
Completion date	November 6, 2016

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms